CD4 and tuberculosis: This large multiregional cohort study analyzed time‐updated age‐ and CD4‐adjusted incidence rates of mortality and first occurrence of WHO‐4 and WHO‐3 events (excluding TB) before and after ART initiation among 65 903 children, adolescents and youth living with PHIV over 259 912 PY of follow‐up.